Peers of INmune Bio Inc (INMB)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
111.12x
As of Mar 30, 2026
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Mar 30, 2026 | 111.12x |
| Mar 27, 2026 | 100.49x |
| Mar 26, 2026 | 143.03x |
| Mar 25, 2026 | 153.66x |
| Mar 24, 2026 | 132.39x |
| Mar 23, 2026 | 164.30x |
| Mar 20, 2026 | 127.08x |
| Mar 19, 2026 | 153.66x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison